Millions of people with type 2 diabetes who take semaglutide, the active ingredient in Ozempic and Wegovy, can draw some ...

Mumbai: An international panel of experts has, for the first time, recognised fatty pancreas disorder (FPD) as a distinct ...

Insurance coverage just changed for as many as 56 million Americans when it comes to the popular GLP-1 medications used to ...

Several popular sugar substitutes may not be as harmless as they seem. Adults who consumed the most artificial sweeteners ...

A Richmond husband and father with a lifelong love for biking is giving back to his daughter and other patients facing type 1 ...

With the recent trial launch of the federal Medicare GLP-1 Bridge program, American medicine has officially stepped into a ...

Novo Nordisk launched oral Wegovy in the U.S. in January. The drug was an instant hit and has maintained strong momentum ...

It has become one of the fastest-growing causes of liver failure and liver transplantation. Many people are living with the ...

CKD is common, especially in older adults, and can result from many different underlying conditions, especially diabetes.

Most ION events occurred in men, patients 50 years or older, with minimal risk seen in women, patients younger than 50 years ...

Novo Nordisk will launch a more affordable authorised copy of its Ozempic diabetes drug in South Africa later this month, partnering with healthcare company Acino to expand ​patient access. The ...

A trio of recent studies suggest that some people can keep the weight off.